Michael Pehl has been appointed CEO of Adcendo, a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for the treatment of cancer. Henrik Stage, co-founder of Adcendo, will move…
Michael Pehl has been appointed CEO of Adcendo, a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for the treatment of cancer. Henrik Stage, co-founder of Adcendo, will move…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


